IBDEI1EQ ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,22761,0)
;;=L94.0^^76^978^20
;;^UTILITY(U,$J,358.3,22761,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22761,1,3,0)
;;=3^Scleroderma,Localized
;;^UTILITY(U,$J,358.3,22761,1,4,0)
;;=4^L94.0
;;^UTILITY(U,$J,358.3,22761,2)
;;=^5009470
;;^UTILITY(U,$J,358.3,22762,0)
;;=D23.9^^76^978^22
;;^UTILITY(U,$J,358.3,22762,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22762,1,3,0)
;;=3^Sebaceous Hyperplasia
;;^UTILITY(U,$J,358.3,22762,1,4,0)
;;=4^D23.9
;;^UTILITY(U,$J,358.3,22762,2)
;;=^5002076
;;^UTILITY(U,$J,358.3,22763,0)
;;=L21.9^^76^978^23
;;^UTILITY(U,$J,358.3,22763,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22763,1,3,0)
;;=3^Seborrhea,Unspec
;;^UTILITY(U,$J,358.3,22763,1,4,0)
;;=4^L21.9
;;^UTILITY(U,$J,358.3,22763,2)
;;=^188703
;;^UTILITY(U,$J,358.3,22764,0)
;;=L91.8^^76^978^39
;;^UTILITY(U,$J,358.3,22764,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22764,1,3,0)
;;=3^Skin Tag
;;^UTILITY(U,$J,358.3,22764,1,4,0)
;;=4^L91.8
;;^UTILITY(U,$J,358.3,22764,2)
;;=^5009460
;;^UTILITY(U,$J,358.3,22765,0)
;;=I83.12^^76^978^42
;;^UTILITY(U,$J,358.3,22765,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22765,1,3,0)
;;=3^Stasis Dermatitis,Left Leg
;;^UTILITY(U,$J,358.3,22765,1,4,0)
;;=4^I83.12
;;^UTILITY(U,$J,358.3,22765,2)
;;=^5007989
;;^UTILITY(U,$J,358.3,22766,0)
;;=I83.11^^76^978^43
;;^UTILITY(U,$J,358.3,22766,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22766,1,3,0)
;;=3^Stasis Dermatitis,Right Leg
;;^UTILITY(U,$J,358.3,22766,1,4,0)
;;=4^I83.11
;;^UTILITY(U,$J,358.3,22766,2)
;;=^5007988
;;^UTILITY(U,$J,358.3,22767,0)
;;=C84.19^^76^978^26
;;^UTILITY(U,$J,358.3,22767,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22767,1,3,0)
;;=3^Sezary Disease,Extranodal/Solid Organ Sites
;;^UTILITY(U,$J,358.3,22767,1,4,0)
;;=4^C84.19
;;^UTILITY(U,$J,358.3,22767,2)
;;=^5001640
;;^UTILITY(U,$J,358.3,22768,0)
;;=C84.13^^76^978^29
;;^UTILITY(U,$J,358.3,22768,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22768,1,3,0)
;;=3^Sezary Disease,Intra-Abdominal Lymph Nodes
;;^UTILITY(U,$J,358.3,22768,1,4,0)
;;=4^C84.13
;;^UTILITY(U,$J,358.3,22768,2)
;;=^5001634
;;^UTILITY(U,$J,358.3,22769,0)
;;=C84.16^^76^978^30
;;^UTILITY(U,$J,358.3,22769,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22769,1,3,0)
;;=3^Sezary Disease,Intrapelvic Lymph Nodes
;;^UTILITY(U,$J,358.3,22769,1,4,0)
;;=4^C84.16
;;^UTILITY(U,$J,358.3,22769,2)
;;=^5001637
;;^UTILITY(U,$J,358.3,22770,0)
;;=C84.12^^76^978^31
;;^UTILITY(U,$J,358.3,22770,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22770,1,3,0)
;;=3^Sezary Disease,Intrathoracic Lymph Nodes
;;^UTILITY(U,$J,358.3,22770,1,4,0)
;;=4^C84.12
;;^UTILITY(U,$J,358.3,22770,2)
;;=^5001633
;;^UTILITY(U,$J,358.3,22771,0)
;;=C84.14^^76^978^25
;;^UTILITY(U,$J,358.3,22771,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22771,1,3,0)
;;=3^Sezary Disease,Axilla/Upper Limb Lymph Nodes
;;^UTILITY(U,$J,358.3,22771,1,4,0)
;;=4^C84.14
;;^UTILITY(U,$J,358.3,22771,2)
;;=^5001635
;;^UTILITY(U,$J,358.3,22772,0)
;;=C84.11^^76^978^27
;;^UTILITY(U,$J,358.3,22772,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22772,1,3,0)
;;=3^Sezary Disease,Head/Face/Neck Lymph Nodes
;;^UTILITY(U,$J,358.3,22772,1,4,0)
;;=4^C84.11
;;^UTILITY(U,$J,358.3,22772,2)
;;=^5001632
;;^UTILITY(U,$J,358.3,22773,0)
;;=C84.15^^76^978^28
;;^UTILITY(U,$J,358.3,22773,1,0)
;;=^358.31IA^4^2
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI1EQ 3760 printed Nov 22, 2024@17:17:28 Page 2
IBDEI1EQ ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,22761,0)
+2 ;;=L94.0^^76^978^20
+3 ;;^UTILITY(U,$J,358.3,22761,1,0)
+4 ;;=^358.31IA^4^2
+5 ;;^UTILITY(U,$J,358.3,22761,1,3,0)
+6 ;;=3^Scleroderma,Localized
+7 ;;^UTILITY(U,$J,358.3,22761,1,4,0)
+8 ;;=4^L94.0
+9 ;;^UTILITY(U,$J,358.3,22761,2)
+10 ;;=^5009470
+11 ;;^UTILITY(U,$J,358.3,22762,0)
+12 ;;=D23.9^^76^978^22
+13 ;;^UTILITY(U,$J,358.3,22762,1,0)
+14 ;;=^358.31IA^4^2
+15 ;;^UTILITY(U,$J,358.3,22762,1,3,0)
+16 ;;=3^Sebaceous Hyperplasia
+17 ;;^UTILITY(U,$J,358.3,22762,1,4,0)
+18 ;;=4^D23.9
+19 ;;^UTILITY(U,$J,358.3,22762,2)
+20 ;;=^5002076
+21 ;;^UTILITY(U,$J,358.3,22763,0)
+22 ;;=L21.9^^76^978^23
+23 ;;^UTILITY(U,$J,358.3,22763,1,0)
+24 ;;=^358.31IA^4^2
+25 ;;^UTILITY(U,$J,358.3,22763,1,3,0)
+26 ;;=3^Seborrhea,Unspec
+27 ;;^UTILITY(U,$J,358.3,22763,1,4,0)
+28 ;;=4^L21.9
+29 ;;^UTILITY(U,$J,358.3,22763,2)
+30 ;;=^188703
+31 ;;^UTILITY(U,$J,358.3,22764,0)
+32 ;;=L91.8^^76^978^39
+33 ;;^UTILITY(U,$J,358.3,22764,1,0)
+34 ;;=^358.31IA^4^2
+35 ;;^UTILITY(U,$J,358.3,22764,1,3,0)
+36 ;;=3^Skin Tag
+37 ;;^UTILITY(U,$J,358.3,22764,1,4,0)
+38 ;;=4^L91.8
+39 ;;^UTILITY(U,$J,358.3,22764,2)
+40 ;;=^5009460
+41 ;;^UTILITY(U,$J,358.3,22765,0)
+42 ;;=I83.12^^76^978^42
+43 ;;^UTILITY(U,$J,358.3,22765,1,0)
+44 ;;=^358.31IA^4^2
+45 ;;^UTILITY(U,$J,358.3,22765,1,3,0)
+46 ;;=3^Stasis Dermatitis,Left Leg
+47 ;;^UTILITY(U,$J,358.3,22765,1,4,0)
+48 ;;=4^I83.12
+49 ;;^UTILITY(U,$J,358.3,22765,2)
+50 ;;=^5007989
+51 ;;^UTILITY(U,$J,358.3,22766,0)
+52 ;;=I83.11^^76^978^43
+53 ;;^UTILITY(U,$J,358.3,22766,1,0)
+54 ;;=^358.31IA^4^2
+55 ;;^UTILITY(U,$J,358.3,22766,1,3,0)
+56 ;;=3^Stasis Dermatitis,Right Leg
+57 ;;^UTILITY(U,$J,358.3,22766,1,4,0)
+58 ;;=4^I83.11
+59 ;;^UTILITY(U,$J,358.3,22766,2)
+60 ;;=^5007988
+61 ;;^UTILITY(U,$J,358.3,22767,0)
+62 ;;=C84.19^^76^978^26
+63 ;;^UTILITY(U,$J,358.3,22767,1,0)
+64 ;;=^358.31IA^4^2
+65 ;;^UTILITY(U,$J,358.3,22767,1,3,0)
+66 ;;=3^Sezary Disease,Extranodal/Solid Organ Sites
+67 ;;^UTILITY(U,$J,358.3,22767,1,4,0)
+68 ;;=4^C84.19
+69 ;;^UTILITY(U,$J,358.3,22767,2)
+70 ;;=^5001640
+71 ;;^UTILITY(U,$J,358.3,22768,0)
+72 ;;=C84.13^^76^978^29
+73 ;;^UTILITY(U,$J,358.3,22768,1,0)
+74 ;;=^358.31IA^4^2
+75 ;;^UTILITY(U,$J,358.3,22768,1,3,0)
+76 ;;=3^Sezary Disease,Intra-Abdominal Lymph Nodes
+77 ;;^UTILITY(U,$J,358.3,22768,1,4,0)
+78 ;;=4^C84.13
+79 ;;^UTILITY(U,$J,358.3,22768,2)
+80 ;;=^5001634
+81 ;;^UTILITY(U,$J,358.3,22769,0)
+82 ;;=C84.16^^76^978^30
+83 ;;^UTILITY(U,$J,358.3,22769,1,0)
+84 ;;=^358.31IA^4^2
+85 ;;^UTILITY(U,$J,358.3,22769,1,3,0)
+86 ;;=3^Sezary Disease,Intrapelvic Lymph Nodes
+87 ;;^UTILITY(U,$J,358.3,22769,1,4,0)
+88 ;;=4^C84.16
+89 ;;^UTILITY(U,$J,358.3,22769,2)
+90 ;;=^5001637
+91 ;;^UTILITY(U,$J,358.3,22770,0)
+92 ;;=C84.12^^76^978^31
+93 ;;^UTILITY(U,$J,358.3,22770,1,0)
+94 ;;=^358.31IA^4^2
+95 ;;^UTILITY(U,$J,358.3,22770,1,3,0)
+96 ;;=3^Sezary Disease,Intrathoracic Lymph Nodes
+97 ;;^UTILITY(U,$J,358.3,22770,1,4,0)
+98 ;;=4^C84.12
+99 ;;^UTILITY(U,$J,358.3,22770,2)
+100 ;;=^5001633
+101 ;;^UTILITY(U,$J,358.3,22771,0)
+102 ;;=C84.14^^76^978^25
+103 ;;^UTILITY(U,$J,358.3,22771,1,0)
+104 ;;=^358.31IA^4^2
+105 ;;^UTILITY(U,$J,358.3,22771,1,3,0)
+106 ;;=3^Sezary Disease,Axilla/Upper Limb Lymph Nodes
+107 ;;^UTILITY(U,$J,358.3,22771,1,4,0)
+108 ;;=4^C84.14
+109 ;;^UTILITY(U,$J,358.3,22771,2)
+110 ;;=^5001635
+111 ;;^UTILITY(U,$J,358.3,22772,0)
+112 ;;=C84.11^^76^978^27
+113 ;;^UTILITY(U,$J,358.3,22772,1,0)
+114 ;;=^358.31IA^4^2
+115 ;;^UTILITY(U,$J,358.3,22772,1,3,0)
+116 ;;=3^Sezary Disease,Head/Face/Neck Lymph Nodes
+117 ;;^UTILITY(U,$J,358.3,22772,1,4,0)
+118 ;;=4^C84.11
+119 ;;^UTILITY(U,$J,358.3,22772,2)
+120 ;;=^5001632
+121 ;;^UTILITY(U,$J,358.3,22773,0)
+122 ;;=C84.15^^76^978^28
+123 ;;^UTILITY(U,$J,358.3,22773,1,0)
+124 ;;=^358.31IA^4^2
